A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1993
12/09/1993	WO1993024117A2 Medicaments for the treatment of anxiety
12/09/1993	WO1993024116A1 Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
12/09/1993	WO1993024115A1 Anti-rheumatoid arthritic drugs in the treatment of dementia
12/09/1993	WO1993024114A1 Reservoir-type plaster containing ketorolac
12/09/1993	WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins
12/09/1993	CA2306952A1 Method for removing dental plaque
12/09/1993	CA2136845A1 Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
12/09/1993	CA2136548A1 Metrifonate-containing medicament
12/09/1993	CA2135394A1 Desferrioxamine-b salts and their use as orally effective iron chelators
12/08/1993	EP0573360A1 Pyrrolothienopyrazine compounds as 5-HT3 receptors antagonists
12/08/1993	EP0573271A1 Angiotensin II antagonists
12/08/1993	EP0573221A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
12/08/1993	EP0572952A1 4-Benzylpiperidine derivatives, a process for preparing them and pharmaceutical compositions containing them
12/08/1993	EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments
12/08/1993	EP0572863A1 CNS pyrazinoindoles
12/08/1993	EP0572852A1 Quinoxalin-2,3(1H,4H)-diones used as medicine
12/08/1993	EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993	EP0572635A1 Novel compounds having a guanidine structure and pharmaceutical composition containing same.
12/08/1993	EP0572560A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
12/08/1993	EP0572455A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists
12/08/1993	EP0572449A1 (amidomethyl)nitrogen heterocyclic analgesics
12/08/1993	EP0368994B1 Benzothiazepines for the preparation of medicaments for the amelioration of epileptic seizures
12/08/1993	CN1079219A Arylacetamides
12/08/1993	CN1023010C Process for preparing 4-heteropentacyctic-4-(N-(phenyl) amido) piperidine derivatives
12/08/1993	CN1023007C Process for preparing pyrrolidine derivatives
12/07/1993	US5268360 Opioid peptides derived from wheat proteins
12/07/1993	CA1325011C Tetrahydronaphthalene and indane derivatives
12/06/1993	CA2097779A1 New pyrrolothienopyrazinic compounds, process for their preparation and pharmaceutical composition containing them
12/06/1993	CA2097465A1 Pyrazinoindoles
12/04/1993	CA2097462A1 Angiotensin ii antagonists
12/02/1993	DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/02/1993	DE4217396A1 Metrifonat enthaltendes Arzneimittel Metrifonate drug containing
12/01/1993	EP0572308A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993	EP0571511A1 Novel ureas and thioureas, preparation thereof and application in therapy.
12/01/1993	EP0571462A1 Prostacycline and carbacycline derivatives as agents for treating feverish complaints
12/01/1993	EP0422154B1 Therapeutic use of 5-ht3 receptor antagonists
12/01/1993	CN1022914C Process for preparation of 1, 3-disubstituted piperidine derivatives
12/01/1993	CA2097141A1 2,3(1h,4h)-quinoxalinediones
11/1993
11/30/1993	US5266570 Piperidine derivatives, compositions and use
11/30/1993	US5266331 Controlled release oxycodone compositions
11/30/1993	CA2097016A1 Pharmaceutical compounds
11/30/1993	CA1324793C 17-aza derivatives of 20, 21-dinoreburnamenine, process for their preparation and their intermediates, their application as medecines and compositions containing them
11/30/1993	CA1324789C 20,21-dinoreburnamenin derivatives substituted in c-15 by an amino group and their salts, process for their preparation and intermediates thus obtained, their application as medicine and pharmaceutical compounds containing them
11/26/1993	CA2096804A1 Heterocyclic derivatives, method of preparation thereof and pharmaceutical compositions which contain them
11/25/1993	WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis
11/25/1993	WO1993023418A1 Purine derivatives
11/25/1993	WO1993023417A1 Novel adenosine derivatives
11/25/1993	WO1993023403A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
11/25/1993	WO1993023399A1 6-AMINO SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS
11/25/1993	WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
11/25/1993	WO1993023396A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
11/25/1993	WO1993023395A1 Heteroaromatic quinuclidinenes, their use and preparation
11/25/1993	WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993	WO1993023383A1 Gaba and l-glutamic acid analogs for antiseizure treatment
11/25/1993	WO1993023380A1 Bridged aza-bicyclic derivatives as substance p antagonists
11/25/1993	WO1993023378A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
11/25/1993	WO1993023045A1 Use of cotinine to alleviate tobacco withdrawal syndrome
11/25/1993	WO1993023035A2 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
11/25/1993	WO1993023025A1 Transdermal administration of oxybutynin
11/25/1993	WO1993023022A1 Solid dispersion compositions of tebufelone
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993	CA2136019A1 Use of cotinine to alleviate tobacco withdrawal syndrome
11/25/1993	CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993	CA2135188A1 6-amino substituted imidazo(4,5-b)pyridines as angiotensin ii antagonists
11/25/1993	CA2134986A1 Fused imidazole and triazole derivatives as 5-htl receptor agonists
11/25/1993	CA2134765A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
11/25/1993	CA2113547A1 Purine derivatives
11/25/1993	CA2113546A1 Novel adenosine derivatives
11/24/1993	EP0571264A1 Autoadhesive matrix system for the transdermal controlled release of piribedil
11/24/1993	EP0571243A1 Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them
11/24/1993	EP0571139A1 Treatment of neurodegenerative diseases
11/24/1993	EP0571012A2 Monoqaternary 2, 16-bispiperidinylandrostane derivatives
11/24/1993	EP0570850A1 Benzo(b)thiophen-3-yl-piperazines, a process for their preparation and their use as medicaments
11/24/1993	EP0570831A2 Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation
11/24/1993	EP0570714A2 Aminoalcohols-n-acylderivatives as therapeutical agents against the neurogenic endoneural oedema developing at the peripheral nerve
11/24/1993	EP0344184B1 Derivatives of (r) 5-pentylamino-5-oxopentanoic acid with anticholecystokinin activity
11/24/1993	CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/24/1993	CN1022828C Process for preparation of aryloxy-arylthio-heteroaryloxy-heteroarylthio-alkenylene derivatives of amines
11/23/1993	US5264619 Anti-androgenic cyclo and bicyclo alkenes
11/23/1993	US5264576 Pyrazolo[4,3-c]pyridines which are intermediates
11/23/1993	US5264443 Psychotropic drugs, antidepressants and anxiolytic agents
11/23/1993	US5264438 Dopamine receptor agonists
11/23/1993	US5264437 Antiinflammatory agents, immunosuppressants or antiallergens
11/23/1993	US5264424 Modified gangliosides and the functional derivatives thereof
11/23/1993	CA1324605C Derivatives of 1-arylsulfonyl-2-pyrrolidionone, process for their preparation and novel intermediates thus obtained, their applications as medecines, and compositions containing them
11/20/1993	CA2096511A1 Selfadhesive matricial system for the transdermal sustained liberation of piribedil
11/19/1993	CA2096406A1 Thiochromanic compounds, method of preparation thereof and pharmaceutical compositions containing them
11/18/1993	EP0569802A1 Arylacetamides
11/18/1993	EP0569777A2 Methods for detecting beta amyloid precursor protein processing enzymes
11/18/1993	EP0569409A1 Amide derivatives and their therapeutic use
11/18/1993	EP0439549B1 Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization
11/18/1993	EP0331743B1 Protein derived from living body
11/17/1993	CN1078471A Pharmaceuticals
11/17/1993	CN1078470A Optionally substituted pyrido \|2,3-d¨ pyrimidine-2,4(1H,3H)-diones and pyrido \|2,3-d¨ pyrimidine-2(1H,3H)-ones
11/17/1993	CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo \|2,3-c¨ pyridin-7-one derivatives
11/16/1993	US5262565 Naphthalene derivatives
11/16/1993	US5262428 Biologically active tropane derivatives
11/16/1993	US5262427 3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions
11/16/1993	US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3

1 ... 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 ... 1833